Glutamic pyruvate transaminase phenotypes in polycythaemia rubra vera.
Glutamate pyruvate transaminase (GPT) has been studied in the red cells of 46 patients with a confirmed diagnosis of polycythaemia rubra vera (PRV). The red cells of many of the patients showed low levels of enzyme activity. This activity could be restored by in vitro incubation with pyridoxal phosphate suggesting that the effect was due to low levels of B6 rather than to a primary abnormality of the GPT. Patients with the lowest levels of GPT activity were likely to have clonal chromosomal abnormalities in the bone marrow cells, particularly 20q-. Among 43 patients in whom the GPT phenotypes could be determined by an electrophoretic method there was a marked deficiency of heterozygotes. This disturbance in phenotypic expression may be related to the clonal nature of the disease in PRV, the clone showing lack of response to homeostatic controls and irregularities of gene expression.
D000410:Alanine Transaminase / Q000097:blood / Q000235:genetics*; D001853:Bone Marrow / Q000648:ultrastructure; D002869:Chromosome Aberrations; D002903:Chromosomes, Human, 19-20; D004912:Erythrocytes / Q000201:enzymology; D005260:Female; D006801:Humans; D008297:Male; D010641:Phenotype; D011087:Polycythemia Vera / Q000201:enzymology* / Q000235:genetics; D011732:Pyridoxal Phosphate / Q000378:metabolism
D011732:Pyridoxal Phosphate; D000410:Alanine Transaminase